Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

CiteULike is a free service for managing and discovering scholarly references - click here to get started.

Sign In to gain access to subscriptions and/or personal tools.
Journal of Human Lactation
This Article
Right arrow Abstract Freely available
Right arrow Free Full Text (Free PDF) Free
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Hartmann, S. U.
Right arrow Articles by Howett, M. K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hartmann, S. U.
Right arrow Articles by Howett, M. K.
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Reviews

Alternative Modified Infant-Feeding Practices to Prevent Postnatal Transmission of Human Immunodeficiency Virus Type 1 Through Breast Milk: Past, Present, and Future

Sandra Urdaneta Hartmann, MD, PhD

Department of Bioscience and Biotechnology at Drexel University in Philadelphia, Pennsylvania

Cheston M. Berlin, MD

Pennsylvania State Children’s Hospital, Pennsylvania State Milton S. Hershey Medical Center in Hershey, Pennsylvania

Mary K. Howett, PhD

Department of Bioscience and Biotechnology of Drexel University in Philadelphia, Pennsylvania

Preventing mother-to-child transmission (MTCT) of human immunodeficiency virus type 1 (HIV-1) through breastfeeding is important to reduce the number of infected children. Research on making breastfeeding safer is a high priority. The authors reviewed the attempts to develop alternative methods, other than antiretroviral (ARV) therapy of mothers and/or babies, to decontaminate breast milk of infectious HIV-1 (free and associated with lymphocytes). They also review how these methods affect milk constituents, as well as their current and prospective status. A PubMed search for English publications on methods to prevent MTCT through breast milk was completed. Methods that have been tested, other than systemicuse or ARV or immunoprophylaxis, to reduce or prevent MTCT of HIV-1 through breast milk were broadly classified into 5 groups: (1) modified feeding practices, (2) heat treatment of milk, (3) lipolysis, (4) antimicrobial treatment of the breastfeeding mother, and (5) microbicidal treatment of infected milk. Their advantages and disadvantages are discussed, as well as future directions in the prevention of MTCT through breastfeeding.

Key Words: breast milk • breastfeeding • human immunodeficiency virus type 1 • HIV-1 • prevention • mother-to-child transmission (MTCT) • microbicides • sodium dodecyl sulfate (SDS) • heat treatment

References

  • The Petra Study Team. Efficacy of three short-course regimens of zidovudine and lamivudine in preventing early and late transmission of HIV-1 from mother to child in Tanzania, South Africa, and Uganda (Petra study): a randomised, double-blind, placebo-controlled trial. Lancet. 2002;359:1178-1186.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Connor EM, Sperling RS, Gelber R, et al. Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group. N Engl J Med. 1994;331:1173-1180.[Abstract/Free Full Text]
  • Dunn DT, Newell ML, Ades AE, Peckham CS. Risk of human immunodeficiency virus type 1 transmission through breastfeeding. Lancet. 1992;340:585-588.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • John GC, Nduati RW, Mbori-Ngacha DA, et al. Correlates of mother-to-child human immunodeficiency virus type 1 (HIV-1) transmission: association with maternal plasma HIV-1 RNA load, genital HIV-1 DNA shedding, and breast infections. J Infect Dis. 2001;183:206-212.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Semba RD, Kumwenda N, Hoover DR, et al. Human immunodeficiency virus load in breast milk, mastitis, and mother-to-child transmission of human immunodeficiency virus type 1. J Infect Dis. 1999;180:93-98.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Embree JE, Njenga S, Datta P, et al. Risk factors for postnatal mother-child transmission of HIV-1. AIDS. 2000;14:2535-2541.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Willumsen JF, Filteau SM, Coutsoudis A, et al. Breast milk RNA viral load in HIV-infected South African women: effects of subclinical mastitis and infant feeding. AIDS. 2003;17:407-414.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Rousseau CM, Nduati RW, Richardson BA, et al. Longitudinal analysis of human immunodeficiency virus type 1 RNA in breast milk and of its relationship to infant infection and maternal disease. J Infect Dis. 2003;187:741-747.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Pillay K, Coutsoudis A, York D, Kuhn L, Coovadia HM. Cell-free virus in breast milk of HIV-1-seropositive women. J Acquir Immune Defic Syndr. 2000;24:330-336.[Web of Science][Medline] [Order article via Infotrieve]
  • Coutsoudis A, Dabis F, Fawzi W, et al. Late postnatal transmission of HIV-1 in breast-fed children: an individual patient data meta-analysis. J Infect Dis. 2004;189:2154-2166.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Richardson BA, John-Stewart GC, Hughes JP, et al. Breast-milk infectivity in human immunodeficiency virus type 1-infected mothers. J Infect Dis. 2003;187:736-740.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • John-Stewart G, Mbori-Ngacha D, Ekpini R, et al. Breast-feeding and transmission of HIV-1. J Acquir Immune Defic Syndr. 2004;35:196-202.[Web of Science][Medline] [Order article via Infotrieve]
  • Becquart P, Chomont N, Roques P, et al. Compartmentalization of HIV-1 between breast milk and blood of HIV-infected mothers. Virology. 2002;300:109-117.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Becquart P, Hocini H, Garin B, Sepou A, Kazatchkine MD, Belec L. Compartmentalization of the IgG immune response to HIV-1 in breast milk. AIDS. 1999;13:1323-1331.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Van de Perre P. Transfer of antibody via mother’s milk. Vaccine. 2003;21:3374-3376.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Lewis P, Nduati R, Kreiss JK, et al. Cell-free human immunodeficiency virus type 1 in breast milk. J Infect Dis. 1998;177:34-39.[Web of Science][Medline] [Order article via Infotrieve]
  • Hoffman IF, Martinson FE, Stewart PW, et al. Human immunodeficiency virus type 1 RNA in breast-milk components. J Infect Dis 2003;188:1209-1212.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Ghosh MK, Kuhn L, West J, et al. Quantitation of human immunodeficiency virus type 1 in breast milk. J Clin Microbiol. 2003;41:2465-2470.[Abstract/Free Full Text]
  • Willumsen JF, Newell ML, Filteau SM, et al. Variation in breast milk HIV-1 viral load in left and right breasts during the first 3 months of lactation. AIDS. 2001;15:1896-1898.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Van de Perre PSA, Hitimana DG, Dabis F, et al. Infective and anti-infective properties of breast milk from HIV-1 infected women. Lancet. 1993;341:914-918.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Rousseau CM, Nduati RW, Richardson BA, et al. Association of levels of HIV-1-infected breast milk cells and risk of mother-to-child transmission. J Infect Dis. 2004;190:1880-1888.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Isaacs CE, Kim KS, Thormar H. Inactivation of enveloped viruses in human bodily fluids by purified lipids. Ann N Y Acad Sci. 1994;724:457-464.[Web of Science][Medline] [Order article via Infotrieve]
  • Orloff SL, Wallingford JC, McDougal JS. Inactivation of human immunodeficiency virus type 1 in human milk: effects of intrinsic factors in human milk and pasteurization. J Hum Lact. 1993;9:13-17.[Abstract/Free Full Text]
  • Newburg DS, Viscidi RP, Ruff A, Yolken RH. A human milk factor inhibits binding of human immunodeficiency virus to the CD4 receptor. Pediatr Res. 1991;31:22-28.
  • Newburg DS, Linhardt RJ, Ampofo SA, Yolken RH. Human milk glycosaminoglycans inhibit HIV glycoprotein gp120 binding to its host cell CD4 receptor. J Nutr. 1995;125:419-424.[Abstract/Free Full Text]
  • Moriuchi M, Moriuchi H. A milk protein lactoferrin enhances human T cell leukemia virus type I and suppresses HIV-1 infection. J Immunol. 2001;166:4231-4236.[Abstract/Free Full Text]
  • Deng H, Liu R, Ellmeier W, et al. Identification of a major co-receptor for primary isolates of HIV-1. Nature. 1996;381:661-666.[CrossRef][Medline] [Order article via Infotrieve]
  • Dragic T, Litwin V, Allaway GP, et al. HIV-1 entry into CD4+ cells is mediated by the chemokine receptor CC-CKR-5. Nature. 1996;381:667-673.[CrossRef][Medline] [Order article via Infotrieve]
  • Nduati RW, John GC, Richardson BA, et al. Human immunodeficiency virus type 1-infected cells in breast milk: association with immunosuppression and vitamin A deficiency. J Infect Dis. 1995;172:1461-1468.[Web of Science][Medline] [Order article via Infotrieve]
  • Dreyfuss ML, Fawzi WW. Micronutrients and vertical transmission of HIV-1. Am J Clin Nutr. 2002;75:959-970.[Abstract/Free Full Text]
  • Bomsel M. Transcytosis of infectious human immunodeficiency virus across a tight human epithelial cell line barrier. Nat Med. 1997;3:42-47.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Van de Perre P. Breast milk transmission of HIV-1: laboratory and clinical studies. Ann N Y Acad Sci. 2000;918:122-127.[Web of Science][Medline] [Order article via Infotrieve]
  • Fotopoulos G, Harari A, Michetti P, Trono D, Pantaleo G, Kraehenbuhl JP. Transepithelial transport of HIV-1 by M cells is receptor-mediated. Proc Natl Acad Sci U S A. 2002;99:9410-9414.[Abstract/Free Full Text]
  • Sheldrake RF, Husband AJ. Intestinal uptake of intact maternal lymphocytes by neonatal rats and lambs. Res Vet Sci. 1985;39:10-15.[Web of Science][Medline] [Order article via Infotrieve]
  • Seelig LL Jr, Billingham RE. Concerning the natural transplantation of maternal lymphocytes via milk. Transplant Proc. 1981;13(pt 2):1245-1249.[Web of Science][Medline] [Order article via Infotrieve]
  • Mohr JA. The possible induction and/or acquisition of cellular hypersensitivity associated with ingestion of colostrum. J Pediatr. 1973;82:1062-1064.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Hanson LA. Breastfeeding provides passive and likely long-lasting active immunity. Ann Allergy Asthma Immunol. 1998;81:523-533; quiz 533-534, 537.[Web of Science][Medline] [Order article via Infotrieve]
  • Hanson LA. The mother-offspring dyad and the immune system. Acta Paediatr. 2000;89:252-258.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Hanson LA, Ceafalau L, Mattsby-Blatzer I, et al. The mammary gland-infant intestine immunologic dyad. Adv Exp Med Biol. 2000;478:65-76.[Web of Science][Medline] [Order article via Infotrieve]
  • Thiry L, Sprecher-Goldberger S, Jonckheer T, et al. Isolation of AIDS virus from cell-free breast milk of three healthy virus carriers. Lancet. 1985;2:891-892.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Southern SO. Milk-borne transmission of HIV: characterization of productively infected cells in breast milk and interactions between milk and saliva. J Hum Virol. 1998;1:328-337.[Medline] [Order article via Infotrieve]
  • Baron S, Poast J, Cloyd MW. Why is HIV rarely transmitted by oral secretions? Saliva can disrupt orally shed, infected leukocytes. Arch Intern Med. 1999;159:303-310.[Abstract/Free Full Text]
  • Baron P, Bremer J, Wasserman SS, et al. Detection and quantitation of human immunodeficiency virus type 1 in the female genital tract. The Division of AIDS Treatment Research Initiative 009 Study Group. J Clin Microbiol. 2000;38:3822-3824.[Abstract/Free Full Text]
  • Shugars DC. Endogenous mucosal antiviral factors of the oral cavity. J Infect Dis. 1999;179(suppl 3): S431-S435.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Omari AA, Luo C, Kankasa C, Bhat GJ, Bunn J. Infant-feeding practices of mothers of known HIV status in Lusaka, Zambia. Health Policy Plan. 2003;18:156-162.[Abstract/Free Full Text]
  • Poggensee G, Schulze K, Moneta I, Mbezi P, Baryomunsi C, Harms G. Infant feeding practices in western Tanzania and Uganda: implications for infant feeding recommendations for HIV-infected mothers. Trop Med Int Health. 2004;9:477-485.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Piwoz EG, Ross J, Humphrey J. Human immunodeficiency virus transmission during breastfeeding: knowledge, gaps, and challenges for the future. Adv Exp Med Biol. 2004;554:195-210.[Web of Science][Medline] [Order article via Infotrieve]
  • Lawrence RA, Lawrence RM. Breastfeeding: A Guide for the Medical Profession. 5th ed. St. Louis, Mo: Mosby, 1999.
  • Karlsson K, Massawe A, Urassa E, et al. Late postnatal transmission of human immunodeficiency virus type 1 infection from mothers to infants in Dar es Salaam, Tanzania. Pediatr Infect Dis J. 1997;16:963-967.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Leroy V, Newell ML, Dabis F, et al. International multicentre pooled analysis of late postnatal mother-to-child transmission of HIV-1 infection. Ghent International Working Group on Mother-to-Child Transmission of HIV. Lancet. 1998;352:597-600.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Coutsoudis A, Pillay K, Spooner E, Kuhn L, Coovadia HM. Influence of infant-feeding patterns on early mother-to-child transmission of HIV-1 in Durban, South Africa: a prospective cohort study. South African Vitamin A Study Group. Lancet. 1999;354:471-476.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Coutsoudis A, Pillay K, Kuhn L, Spooner E, Tsai WY, Coovadia HM. Method of feeding and transmission of HIV-1 from mothers to children by 15 months of age: prospective cohort study from Durban, South Africa. AIDS. 2001;15:379-387.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Leroy V, Becquet R, Rouet F, et al. Postnatal transmission risk according to feeding modalities in children born to HIV-infected mothers in a PMTCT project in Abidjan Côte d’Ivoire. DITRAME PLUS project ANRS 1201/1202 (Abstract No. MoPpB2007). XV International AIDS Conference 2004, Bangkok, Thailand.
  • Piwoz E, Iliff P, Tavengwa N, et al. Early introduction of non-human milk and solid food increases the risk of postnatal HICV-1 transmission in Zimbabwe (Abstract No. MoPpB2008). XV International AIDS Conference 2004, Bangkok, Thailand.
  • World Health Organization. New Data on the Prevention of Mother-to-Child Transmission of HIV and Their Policy Implications—Conclusions and Recommendations. Geneva, Switzerland: UNFPA/UNICEF/WHO/UNAIDS Inter-Agency Task Team on Mother-to-Child Transmission of HIV; 2000.
  • WHO-UNAIDS-UNICEF. Technical Consultation on HIV and Infant Feeding. Geneva, Swtizerland; 1998.
  • Rollins N, Meda N, Becquet R, et al. Preventing postnatal transmission of HIV-1 through breast-feeding: modifying infant feeding practices. J Acquir Immune Defic Syndr. 2004;35:188-195.[Web of Science][Medline] [Order article via Infotrieve]
  • Smith MM, Kuhn L. Exclusive breast-feeding: does it have the potential to reduce breast-feeding transmission of HIV-1? Nutr Rev. 2000;58:333-340.[Web of Science][Medline] [Order article via Infotrieve]
  • Piwoz E, Huffman S, Lusk D, Zehner E, CO OG. Early Breastfeeding Cessation as an Option for Reducing Postnatal Transmission of HIV in Africa: Issues, Risks, and Challenges. Washington, DC: Academy for Educational Development; 2001.
  • Kiarie JN, Richardson BA, Mbori-Ngacha D, Nduati RW, John-Stewart GC. Infant feeding practices of women in a perinatal HIV-1 prevention study in Nairobi, Kenya. J Acquir Immune Defic Syndr. 2004;35:75-81.[Web of Science][Medline] [Order article via Infotrieve]
  • UNAIDS. AIDS Epidemic Update—December 2002: Joint United Nations Programme on HIV/AIDS. 2002.
  • Tully MR. Is pasteurized mother’s own or donor milk an answer to the HIV crisis? J Hum Lact. 1999;15:345-346.[Free Full Text]
  • Pennypacker C, Perelson AS, Nys N, Nelson G, Sessler DI. Localized or systemic in vivo heat inactivation of human immunodeficiency virus (HIV): a mathematical analysis. J Acquir Immune Defic Syndr Hum Retrovirol. 1995;8:321-329.[Web of Science][Medline] [Order article via Infotrieve]
  • McDougal JS, Martin LS, Cort SP, Mozen M, Heldebrant CM, Evatt BL. Thermal inactivation of the acquired immunodeficiency syndrome virus, human T lymphotropic virus-III/lymphadenopathy-associated virus, with special reference to antihemophilic factor. J Clin Invest. 1985;76:875-877.[Web of Science][Medline] [Order article via Infotrieve]
  • Ford JE, Law BA, Marshall VM, Reiter B. Influence of the heat treatment of human milk on some of its protective constituents. J Pediatr. 1977;90:29-35.[Web of Science][Medline] [Order article via Infotrieve]
  • Boisen F, Jørgensen A. Pasteurization of HIV contaminated breast milk (Abstract No. LbPp122). XIII International AIDS Conference 2000, July 7-12, 2000, Durban, South Africa.
  • Jørgensen A, Nøhr K. Cholera: water pasteurization using solar energy. Tropical Doctor. 1995;25:175.[Web of Science][Medline] [Order article via Infotrieve]
  • Madsen BF. Solar-powered device inactivates HIV in breast milk. Reuters Health Information Services. 2000.
  • Solar-powered device decontaminates human immunodeficiency virus (HIV)-infected breast milk. J Soc Gynecol Investig. 2000;7:366.[Medline] [Order article via Infotrieve]
  • Chantry CJ, Morrison P, Panchula J, et al. Effects of lipolysis or heat treatment on HIV-1 provirus in breast milk. JAIDS. 2000;24:325-329.
  • Israel-Ballard K, Donovan R, Enge B, et al. A novel approach for evaluating pasteurization methods to inactivate HIV in breast milk, Poster #899. 11th Conference on Retroviruses and Opportunistic Infections; February 1-8, 2004; San Francisco, CA.
  • Jeffery BS, Mercer KG. Pretoria pasteurisation: A potential method for the reduction of postnatal mother to child transmission of the human immunodeficiency virus. J Trop Pediatr. 2000;46:219-223.[Abstract/Free Full Text]
  • Jeffery BS, Webber L, Mokhondo KR, Erasmus D. Determination of the effectiveness of inactivation of human immunodeficiency virus by Pretoria pasteurization. J Trop Pediatr. 2001;47:345-349.[Abstract/Free Full Text]
  • Israel-Ballard K, Chantry C, Donovan R, et al. Viral, nutritional, and bacterial safety of flash-heated and Pretoria-pasteurized breast milk to prevent mother-to-child transmission of HIV in resource-poor countries: a pilot study (Abstract No. ThPeC7411). XV International AIDS Conference 2004; Bangkok, Thailand.
  • Papathakis P, Rollins N. Adequacy of feeding recommendations for infants of HIV-infected mothers: assessment of nutrient content, cost and preparation time of breast milk replacements in the South African context (Abstract No. MoOrF1030). XIV International AIDS Conference; July 7-12, 2004; Barcelona, Spain.
  • Papathakis P, Rollins N. Are WHO/UNAIDS/UNICEF-recommended replacement milks for infants of HIV-infected mothers appropriate in the South African Context? Bull World Health Organ. 2004;84:164-171.[CrossRef]
  • Thormar H, Isaacs CE, Brown HR, Barshatzky MR, Pessolano T. Inactivation of enveloped viruses and killing of cells by fatty acids and monoglycerides. Antimicrob Agents Chemother. 1987;31:27-31.[Abstract/Free Full Text]
  • Sperber K, Louie M, Kraus T, et al. Hydroxychloroquine treatment of patients with human immunodeficiency virus type 1. Clin Ther. 1995;17:622-636.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Sperber K, Chiang G, Chen H, et al. Comparison of hydroxychloroquine with zidovudine in asymptomatic patients infected with human immunodeficiency virus type 1. Clin Ther. 1997;19:913-923.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Tsai WP, Nara PL, Kung HF, Oroszlan S. Inhibition of human immunodeficiency virus infectivity by chloroquine. AIDS Res Hum Retroviruses. 1990;6:481-489.[Web of Science][Medline] [Order article via Infotrieve]
  • Sperber K, Kalb TH, Stecher VJ, Banerjee R, Mayer L. Inhibition of human immunodeficiency virus type 1 replication by hydroxychloroquine in T cells and monocytes. AIDS Res Hum Retroviruses. 1993;9:91-98.[Web of Science][Medline] [Order article via Infotrieve]
  • Poli G, Bressler P, Kinter A, et al. Interleukin 6 induces human immunodeficiency virus expression in infected monocytic cells alone and in synergy with tumor necrosis factor alpha by transcriptional and post-transcriptional mechanisms. J Exp Med. 1990;172:151-158.[Abstract/Free Full Text]
  • Savarino A, Gennero L, Chen HC, et al. Anti-HIV effects of chloroquine: mechanisms of inhibition and spectrum of activity. AIDS. 2001;15:2221-2229.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Ogunbona FA, Onyeji CO, Bolaji OO, Torimiro SE. Excretion of chloroquine and desethylchloroquine in human milk. Br J Clin Pharmacol. 1987;23:473-476.[Web of Science][Medline] [Order article via Infotrieve]
  • Nation RL, Hackett LP, Dusci LJ, Ilett KF. Excretion of hydroxychloroquine in human milk. Br J Clin Pharmacol. 1984;17:368-369.[Web of Science][Medline] [Order article via Infotrieve]
  • Costedoat-Chalumeau N, Amoura Z, Aymard G, et al. Evidence of transplacental passage of hydroxychloroquine in humans. Arthritis Rheum. 2002;46:1123-1124.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Boelaert JR, Yaro S, Augustijns P, et al. Chloroquine accumulates in breast-milk cells: potential impact in the prophylaxis of postnatal mother-to-child transmission of HIV-1. AIDS. 2001;15:2205-2207.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Webster L Jr. Drugs used in the chemotherapy of protozoal infections. Malaria. In: Gilman AG, Rall TW. Taylor P, eds. Goodman and Gilman’s. The Pharmacological Basis of Therapeutics.8thed. New York, NY: Pergamon Press; 1990:978-998.
  • Motta M, Tincani A, Faden D, Zinzini E, Chirico G. Antimalarial agents in pregnancy. Lancet. 2002;359:524-525.[Web of Science][Medline] [Order article via Infotrieve]
  • Wolfe MS, Cordero JF. Safety of chloroquine in chemosuppression of malaria during pregnancy. Br Med J. 1985;290:1466-1467.[Abstract/Free Full Text]
  • Klinger G, Morad Y, Westall CA, et al. Ocular toxicity and antenatal exposure to chloroquine or hydroxychloroquine for rheumatic diseases. Lancet. 2001;358:813-814.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Browning DJ. Hydroxychloroquine and chloroquine retinopathy: screening for drug toxicity. Am J Ophthalmol. 2002;133:649-656.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Hitchcock PJ. Topical microbicides. In: Stanberry L, Bernstein D, eds. Sexually Transmitted Diseases: Vaccines, Prevention, and Control. San Diego, Calif: Academic Press; 2000:149-184.
  • Howett M, Kuhl J. Microbicides for prevention of transmission of sexually transmitted diseases. In: Parang K, ed. Current Pharmaceutical Design: HIV Drug Design (Anti-HIV Agents). Ewing Township, NJ: Bentham Science Publishers Ltd. In press.
  • Krebs FC, Miller SR, Malamud D, Howett MK, Wigdahl B. Inactivation of human immunodeficiency virus type 1 by nonoxynol-9, C31G, or an alkyl sulfate, sodium dodecyl sulfate. Antiviral Res. 1999;43:157-173.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Howett MK, Neely EB, Christensen ND, et al. A broad-spectrum microbicide with virucidal activity against sexually transmitted viruses. Antimicrob Agents Chemother. 1999;43:314-321.[Abstract/Free Full Text]
  • Howett MK, Stoltzfus SU, Berlin CM, Wigdahl B. Inactivation of HIV in Milk by Alkyl Sulfate Microbicides. XIII International AIDS Conference 2000; July 7-12, 2000; Durban, South Africa.
  • Krebs FC, Miller SR, Catalone BJ, et al. Sodium dodecyl sulfate and C31G as microbicidal alternatives to nonoxynol 9: comparative sensitivity of primary human vaginal keratinocytes. Antimicrob Agents Chemother. 2000;44:1954-1960.[Abstract/Free Full Text]
  • Howett MK, Welsh PA, Budgeon LR, et al. Transformation of human vaginal xenografts by human papillomavirus type 11: prevention of infection with a microbicide from the alkyl sulfate chemical family. Pathogenesis. 2000;1:265-276.
  • Kristmundsdottir T, Arnadottir SG, Bergsson G, Thormar H. Development and evaluation of microbicidal hydrogels containing monoglyceride as the active ingredient. J Pharm Sci. 1999;88:1011-1015.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Thormar H, Bergsson G, Gunnarsson E, et al. Hydrogels containing monocaprin have potent microbicidal activities against sexually transmitted viruses and bacteria in vitro. Sex Transm Infect. 1999;75:181-185.[Abstract]
  • Neyts J, Kristmundsdottir T, De Clercq E, Thormar H. Hydrogels containing monocaprin prevent intravaginal and intracutaneous infections with HSV-2 in mice: impact on the search for vaginal microbicides. J Med Virol. 2000;61:107-110.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Maguire RA, Bergman N, Phillips DM. Comparison of microbicides for efficacy in protecting mice against vaginal challenge with herpes simplex virus type 2, cytotoxicity, antibacterial properties, and sperm immobilization. Sex Transm Dis. 2001;28:259-265.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • The Population Council. Carraguard—the Population Council’s Lead Candidate Microbicide. New York, NY: The Population Council;2002.
  • United Nations Environment Programme. Screening Information Data Sheet (SIDS) for High Volume Chemicals. Initial Assessment Report on Sodium Dodecyl Sulfate (CAS No. 151-21-3). Geneva, Switzerland: UNEP.
  • US Food and Drug Administration. EAFUS: A Food Additive Database. College Park, Md: Center for Food Safety and Applied Nutrition. Office of Food Additive Safety; 2002.
  • Yao G. Dodecyl Sulfate Degradation Pathway Map. Available at: http://www.labmed.umn.edu/umbbd.dds/dds_map.html.
  • Isaacs CE. The antimicrobial function of milk lipids. Adv Nutr Res. 2001;10:271-285.[Web of Science][Medline] [Order article via Infotrieve]
  • Isaacs CE, Kashyap S, Heird WC, Thormar H. Antiviral and antibacterial lipids in human milk and infant formula feeds. Arch Dis Child. 1990;65:861-864.[Abstract/Free Full Text]
  • Isaacs CE, Thormar H, Pessolano T. Membrane-disruptive effect of human milk: inactivation of enveloped viruses. J Infect Dis. 1986;154:966-971.[Web of Science][Medline] [Order article via Infotrieve]
  • Bergsson G, Arnfinnsson J, Karlsson SM, Steingrimsson O, Thormar H. In vitro inactivation of Chlamydia trachomatis by fatty acids and monoglycerides. Antimicrob Agents Chemother. 1998;42:2290-2294.[Abstract/Free Full Text]
  • Urdaneta S, Neely EB, Stiller C, et al. Antiviral activity of alkyl sulfates and the synthetic derivate octylglycerol in human milk for prevention of transmission of HIV-1. In preparation.
  • O’Niel MJ, Budavari S, Smith A, et al, eds. The Merck Index: An Encyclopedia of Chemicals, Drugs, and Biologicals. 13th ed. Whitehouse Station: Merck & Co Inc; 2001.
  • Schols D, Pauwels R, Desmyter J, De Clercq E. Dextran sulfate and other polyanionic anti-HIV compounds specifically interact with the viral gp120 glycoprotein expressed by T-cells persistently infected with HIV-1. Virology. 1990;175:556-561.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Baba M, Schols D, Pauwels R, Nakashima H, De Clercq E. Sulfated polysaccharides as potent inhibitors of HIV-induced syncytium formation: a new strategy towards AIDS chemotherapy. J Acquir Immune Defic Syndr. 1990;3:493-499.[Medline] [Order article via Infotrieve]
  • Witvrouw M, De Clercq E. Sulfated polysaccharides extracted from sea algae as potential antiviral drugs. Gen Pharmacol. 1997;29:497-511.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Urdaneta S, Neely EB, Stiller C, et al. Inactivation of HIV-1 in human milk with carrageenan-based microbicides. In preparation.
  • Isaacs CE, Thormar H. The role of milk-derived antimicrobial lipids as antiviral and antibacterial agents. Adv Exp Med Biol. 1991;310:159-165.[Medline] [Order article via Infotrieve]
  • Urdaneta Stoltzfus S, Berlin CM, Wigdahl W, Howett M. Use of sodium dodecyl sulfate as a microbicide for HIV inactivation in breast milk [abstract]. Pediatr Res. 2001;49:253A.
  • Urdaneta SL, Berlin CM, Wigdahl B, Howett MK. Prevention of mother-to-child transmission of HIV-1 by treatment of HIV-1-infected breast milk with alkyl sulfate microbicides (Abstract No. TuPeF5420). In: Proceedings XIV International AIDS Conference 2002; July 7-12, 2002. Barcelona, Spain: Monduzzi Editore S.p.A.-Medimond Inc; 135-139.
  • Urdaneta S, Wigdahl B, Neely EB, et al. Microbicidal treatment of HIV-1 infected breast milk as an alternative for prevention of mother-to-child transmission of HIV-1 through breastfeeding. In: Proceedings of XV International AIDS Conference 2004; July 11-16, 2004. Bangkok, Thailand: Monduzzi Editore; 135-138.
  • Urdaneta S, Wigdahl B, Neely EB, et al. Inactivation of HIV-1 in breast milk by treatment with the alkyl sulfate microbicide sodium dodecyl sulfate (SDS). Retrovirology. 2005;2:28.[CrossRef][Medline] [Order article via Infotrieve]
  • Hartmann SU, Wigdahl B, Neely EB, et al. Biochemical analysis of human milk treated with sodium dodecyl sulfate, an alkyl sulfate microbicide that inactivates Human Immunodeficiency Virus Type 1. J Hum Lact. 2006;22:61-74.[Abstract/Free Full Text]
  • Dreisbach RH, Robertson WO. Miscellaneous chemicals. In: Handbook of Poisoning: Prevention, Diagnosis and Treatment. 12th ed. Norwalk, Conn: Appleton & Lange; 1987:286-291.
  • Gloxhuber C, Kunstler K. Anionic Surfactants: Biochemistry, Toxicology, Dermatology. 2nd ed. New York, NY: Marceld Dekker; 1992.
  • UNAIDS. AIDS Epidemic Update—December 2003. Geneva, Switzerland: Joint United Nations Programme on HIV/AIDS; 2003.

Journal of Human Lactation, Vol. 22, No. 1, 75-88 (2006)
DOI: 10.1177/0890334405280650
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
 J Hum LactHome page
S. U. Hartmann, B. Wigdahl, E. B. Neely, C. M. Berlin, C.-L. Schengrund, H.-M. Lin, and M. K. Howett
Biochemical Analysis of Human Milk Treated With Sodium Dodecyl Sulfate, an Alkyl Sulfate Microbicide That Inactivates Human Immunodeficiency Virus Type 1
J Hum Lact, February 1, 2006; 22(1): 61 - 74.
[Abstract] [PDF]

This Article
Right arrow Abstract Freely available
Right arrow Free Full Text (Free PDF) Free
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Hartmann, S. U.
Right arrow Articles by Howett, M. K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hartmann, S. U.
Right arrow Articles by Howett, M. K.
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?